Alnylam Pharmaceuticals (NASDAQ: NASDAQ:ALNY) stock climbed 5% as trading resumed on Friday morning, following the company’s announcement that the FDA has approved AMVUTTRA for treating ATTR ...
Investing.com - Canada’s main stock index futures inched lower on Friday after equities fell in the prior session. By 06:59 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback